According to CCTV News, recently, the National Medical Products Administration approved the innovative product registration application of Neuracle Technology (Shanghai) Co., Ltd. for its implantable brain-computer interface hand motor function compensation system, marking the world's first launch of a brain-computer interface medical device. This signifies that the world’s first invasive brain-computer interface medical device has entered the clinical application stage.
This product consists of a brain-computer interface implant, an implantable EEG electrode kit, an EEG signal transceiver, a pneumatic glove device, a disposable surgical tool kit, EEG decoding software, medical testing software, and clinical management software. It is suitable for patients with quadriplegia caused by cervical spinal cord injury, assisting in achieving hand grasp function compensation through the pneumatic glove device. Patients must meet the following criteria: aged 18 to 60, with C2-C6 cervical spinal cord injury graded A-C on the ASIA scale, diagnosed for over one year and with stable condition for at least six months after standardized treatment, unable to perform hand grasping but retaining partial upper arm function. The product adopts minimally invasive epidural implantation and wireless power supply communication technology. Clinical trial results show that subjects using this product have significantly improved hand grasping ability, thereby enhancing their quality of life.
(Reporters from CCTV News Channel, Zhang Yun and Liang Zhi)
Editor: Li Yilinzi